Community Investing Ideas

Global Weekly Picks

US$387.77
FV
34.5% undervalued intrinsic discount
13.68%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
US$25.55
3.3% overvalued intrinsic discount
Bejgal Fair Value
Revenue growth
12% p.a.
Profit Margin
29%
Future PE
12x
Share price in 2027
US$38.86
US$19.9
15.8% undervalued intrinsic discount
Chester Fair Value
Revenue growth
10% p.a.
Profit Margin
20%
Future PE
24x
Share price in 2030
US$35.07
MRK logo
Merck

Acqusition and awaiting analysis

Merck & Co., Inc. (NYSE:MRK) shares have moved higher as investors cheered a key FDA filing and strategic acquisition, while digesting trimmed earnings forecasts.Read more

View narrative
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
US$74
17.2% overvalued intrinsic discount
Revenue growth
2.84% p.a.
Profit Margin
27.27%
Future PE
12.06x
Share price in 2030
US$100.94
US$5.97
46.1% undervalued intrinsic discount
Revenue growth
1.86% p.a.
Profit Margin
0.67%
Future PE
35.19x
Share price in 2028
US$7.31